Big Cannabis – on the lines of Big Pharma – is on the cards. At least that’s what Germany-based pharmaceutical giant Bayer’s $66 billion takeover of America-based agrichemical giant Monsanto (a leading producer of RoundUp Ready genetically modified crops) indicates.
Financed from a consortium of corrupt, in-debt, and influential banks (including Goldman Sachs, HSBC, JP Morgan, and Bank of America), the multi-billion-dollar deal (negotiated by the Rothschild Banking Cartel) brings Bayer (famous for selling heroin to children and financing Nazi concentration camps) closer to the multi-billion-dollar cannabis market through its ”mission” to create a one-stop shop for seeds, crop chemicals and computer-aided services to cannabis growers.
— David (@rskls) September 6, 2016
Cannabis proponents believe the largest all-cash deal on record will destroy the infant marijuana industry by introducing genetically modified cannabis seeds, highly expensive cannabis-based drugs, monopolistic use of patents, and restrictive business practices. Leafly notes:
“The worry is that the combined firm will have the financial and political influence to do to cannabis what it has already done to corn, tobacco, and other cash crops — namely, use pricey patented cannabis seeds (Roundup Ready Blue Dream, anyone?) that favor large-scale operators and rigidly control how all cannabis farmers farm. The merger, in other words, could be the first step toward Big Cannabis.”
Monsanto’s decades old intimate ties with the Scotts Miracle-Gro Company — a leading producer of pesticides for commercial and consumer lawn and garden use (who was ordered to pay $12.5 million in criminal fines and civil penalties for violations of Federal Pesticide Laws in 2012) — is especially a matter of concern. Monsanto and Scotts Miracle-Gro have long been partners with the DEA to produce hormones and carcinogenic chemicals used in the wars against marijuana and coca plants.
Jim Hagedorn, who took over Scotts Miracle-Gro in 2001, shared his intention to “invest, like, half a billion in the pot business” with Forbes in July, calling cannabis the biggest thing he has ever seen in lawn and garden. Forbes reports:
Scotts Miracle-Gro shelled out $135 million last year on two California-based businesses [including the $130 million buyout of General Hydroponics] that sell fertilizers, soils and accessories to pot growers. It recently spent another $120 million on a still-undisclosed lighting and hydroponics equipment company in Amsterdam and promises to invest about another $150 million by the end of 2016.
Altogether, the deals are bigger than the largest single acquisition in the history of Scotts Miracle-Gro, which takes in $160 million of profit on $3 billion in sales annually.
In August, Scotts Miracle-Gro announced it spent $136 million (via its subsidiary Hawthorne Gardening) to buy Gavita, a Dutch maker of hydroponics gardening lights with close ties to marijuana. In the same month, Scotts signed a $40 million deal to acquire Botanicare, a marijuana nutrient and hydroponics products provider in Arizona.
— Jurgen (@Apneac) October 21, 2016
Bayer, on its part, has been working with GW Pharmaceuticals — a UK-based biopharmaceutical company that grows marijuana, extracts compounds from it, and turns the compounds into prescription cannabinoid medicines — on a cannabis-based medicinal extract, since 2003.
Moreover, Bayer exclusively sells some of GW Pharmaceuticals’ products, including Sativex — a whole cannabis extract that comes as a peppermint-flavored mouth spray — to treat the debilitating symptoms of multiple sclerosis and severe neuropathic pain.
— Letitia E. Pepper (@letitiaepepper) September 29, 2016
Michael Straumietis, founder and owner of hydroponics nutrients company Advanced Nutrients, has constantly warned the marijuana community about Monsanto, Scotts Miracle-Gro, GMO marijuana, and corporate takeover of the marijuana industry.
“Monsanto and Bayer have an agreement to share information about genetically modifying crops including cannabis. Bayer is partnered with GW Pharmaceuticals, which grows its own proprietary marijuana genetics. You can bet Monsanto and Bayer are interested in creating GMO marijuana.”
Straumietis warns Monsanto-Scotts, Bayer-GW Pharmaceuticals, and Monsanto-Bayer tie-ups are disastrous for the cannabis industry, as they have the potential to control the world’s seed supply, food supply, agricultural chemicals, fertilizers, and medicines.
“These corporations have reduced the variety and availability of native seeds. They genetically modify crops so farmers have to buy new seeds every year, and use corporate chemicals like RoundUp to grow them. They’d do the same thing with GMO marijuana.”
Do you think the Bayer-Monsanto deal is a threat to the traditional cannabis industry? Please share your thoughts in the comments section below…
This article (War on Weed: Bayer-Monsanto Working on Genetically Modified Corporate Cannabis?) is a free and open source. You have permission to republish this article under a Creative Commons license with attribution to the author and AnonHQ.com.
Click here to follow us on steemit.com, the decentralized social media platform with no censorship and get paid for your posts, likes and comments!